Genmab
GMAB NASDAQ
Medicare add-on payments
- New
- 0
- Continued
- 0
- Lost
- 1
| Status | Technology | Max add-on payment | Implied cost per case |
|---|---|---|---|
| Lost | EPKINLY (epcoritamab-bysp) and COLUMVI (glofitamab-gxbm) | $6,504prior-year maximum | $10,006 |
FDA device recalls, last 36 months
FDA data as of . Source: openFDA. FDA data may be out of date.
MediDash tracks device recalls only. No device recalls are matched to this company.